The abstract is read at the publisher; the summary is JClub's.
Focused ultrasound-mediated blood-brain barrier opening (FUS-BBBO) enables systemically delivered AAVs to enter targeted brain regions at high local concentrations while limiting non-target transduction.
- Why it matters: AAV brain delivery depends on trade-offs among dose, cellular delivery efficacy, and covered brain volume, and existing clinical strategies can be invasive, limited in coverage, or risk peripheral/global exposure.
- What they did: This review explains how FUS uses microbubble cavitation to transiently and locally increase BBB permeability at user-defined targets, and discusses progress in large-volume sonication and FUS-optimized AAV capsids.
- The result: The converging engineering advances are positioned to support a clinically translatable paradigm that is non-invasive, regionally selective, and highly efficient for CNS gene delivery.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.